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BACKGROUND Stenting of small vessels might be associated with
higher rates of adverse events. The relationship between stent strut
thickness and adverse clinical events remains particularly evident in
smaller vessels. Recently published trial showed biolimus A9-eluting
stent (BES) was non-inferior with sirolimus-eluting stent. However,
the stainless steel stent platform of BES has a strut thickness of 112
mm. We assessed the impact of vessel size on clinical outcomes of
stenting with BES.
METHODS The BEUTY registry was conducted to assess clinical per-
formance of BiomatrixTM BES implantation in an unrestricted “real-
world” cohort of patients with acute coronary syndrome (ACS) be-
tween May 2011 and July 2013. Clinical outcomes from the BEAUTY
database were compared between patients with small (reference
vessel diameter [RVD]  2.75 mm) versus large (RVD > 2.75 mm)
vessels. The primary endpoint was target vessel failure (TVF) deﬁned
as a composite of cardiac death, myocardial infarction, or clinical-
driven target vessel revascularization at 12 months.
RESULTS Of 1,000 ACS patients with 1,251 lesions, 238 patients with
271 lesions had small vessel treated (n¼238, 23.8%) and large vessel
treated (n¼756, 75.6%). Patients included in the small vessel group
presented clinical proﬁles characterized by higher proportion of older
age, diabetes, lower estimated creatinine clearance, multi-vessel
coronary disease, or post-procedural TIMI ﬂow grade <3. Patients in
the small vessel group had a strong tendency of higher occurrence of
TVF compared with those in the large vessel group (3.8% vs. 1.9%,
unadjusted hazard ratio [HR] 2.05; 95% conﬁdence interval [CI] 0.89-
4.75; p ¼ 0.09). In multivariate Cox proportional hazard analysis using
age, diabetes, left ventricular ejection fraction, and aspirin duringhospitalization, the small vessel group still showed a signiﬁcantly
higher incidence of TVF (adjusted HR 2.84; 95% CI 1.15 to 6.99; p ¼
0.023). The rate of TVF was consistently higher in the small vessel
group than in the large vessel group across various high-risk
subgroups.
CONCLUSIONS Stenting of BES at the small vessel appears to increase
the risk of TVF in patients with ACS. Thus, in the PCI of the small
vessels with BMS, cautions should be needed to obtain the best
optimal results.
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BACKGROUND Stent fracture (SF) is related to restenosis after drug-
eluting stent (DES) implantation. Although SF is rare complication in
the era of new generation DES, the frequency of the SF per lesion is
not known so much. We research the frequency of the SF per lesion,
and compare between ﬁrst and new generation DES implantation.
METHODS From November 2002 to May 2014, 10904 patients with
18068 lesions underwent DES implantation successfully. Of these,
14350 lesions were angiographically followed up after 6 to 8 months
(midterm f/u) and 11387 lesions were followed up at 12 months after
midterm f/u. First generation DES was deﬁned as SES and PES. New
generation DES was deﬁned as EES and BES.
RESULTS The frequency of the SF in new generation DES is lower
than that of the ﬁrst generation DES (2.5% vs. 5.5%, P value < 0.005).
This tendency applies, even in per lesion, especially in left anterior
descending (LAD) artery. And, in the restenosis lesion, left anterior
descending artery only decreases the frequency of the SF (0% vs.
2.3%, P value < 0.05). The frequency of the SF in right coronary artery
(RCA) is higher than that in left coronary artery (LCA). The restenosis
ratio in SF lesion is about 30%, and it is not improved even in new
generation DES.
Table 1. Total number of Stent Fracture1st. DES total 2nd. DES total P valueRCA 9.1%(264/2912) 5.6%(137/2452) < 0.001LMT 3.4%(27/795) 1.2%(8/655) 0.009LAD 3.6%(116/3203) 0.5%(15/2870) < 0.001LCX 3.2%(59/1833) 1.4%(21/1549) < 0.001total 5.5%(441/8042) 2.5%(175/6925) < 0.001
